Six biotechs crowd into Nasdaq, raising $568M as the IPO party continues to lure companies to Wall Street
Usually biotech IPOs come one or maybe two at a time. Today, we have 5 simultaneously testing investors’ appetite for risky companies that will either …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
